Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Diagnosing a mental health patient with a precise clinical disorder can be a difficult undertaking, and some types of mental disorders are particularly easily confused with others. In most situations, allowing concurrent diagnoses of different clinical disorders ' and even being generally over-inclusive in identifying a patient's different disorders ' is not harmful to the patient. In the case of the diagnosis of “obsessive compulsive disorder” (OCD), however, a misdiagnosis may send the patient down the wrong treatment path entirely. Such misdiagnoses can be particularly prevalent where OCD patients are abusing substances in an effort to self-medicate. But no matter the difficulties, misdiagnosed patients may have a viable claim for medical malpractice, so knowing the common diagnostic pitfalls is helpful.
Making the Diagnosis
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.